机构:[1]Department of Urology, Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.[2]Department of Urology, West China Hospital of Sichuan University, Chengdu 610041, China.四川大学华西医院[3]Zhengding Country People's Hospital, Zhengding, China.[4]Department of Urology, First Hospital of Jiaxing, Jiaxing 314033, China.[5]Department of Urology, The First Hospital of Hebei Medical University, Shijiazhuang 050023, China.[6]Department of Pathology, Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University, Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang 050017, China.
This study was supported by the Hebei Province Natural Science Foundation (H2020206146, H2022206402).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区生物学
小类|3 区细胞生物学
最新[2023]版:
大类|2 区生物学
小类|3 区细胞生物学
第一作者:
第一作者机构:[1]Department of Urology, Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Guo Fengran,Gao Yilong,Zhou Pengfei,et al.Single-cell analysis reveals that TCF7L2 facilitates the progression of ccRCC via tumor-associated macrophages[J].Cellular Signalling.2024,124:111453.doi:10.1016/j.cellsig.2024.111453.
APA:
Guo Fengran,Gao Yilong,Zhou Pengfei,Wang Hu,Ma Ziyang...&Han Zhenwei.(2024).Single-cell analysis reveals that TCF7L2 facilitates the progression of ccRCC via tumor-associated macrophages.Cellular Signalling,124,
MLA:
Guo Fengran,et al."Single-cell analysis reveals that TCF7L2 facilitates the progression of ccRCC via tumor-associated macrophages".Cellular Signalling 124.(2024):111453